Trial Profile
A study evaluating efficacy of rotigotine, pramipexole LA or ropinirole CR in treating freezing of gait (FOG) in patients with Parkinson's disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2017
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary) ; Ropinirole (Primary) ; Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 10 May 2017 New trial record
- 28 Apr 2017 Results (n=111) presented at the 69th Annual Meeting of the American Academy of Neurology